Atrandi Biosciences Secures $25M Series A Funding for U.S. Expansion
Deal News | Feb 19, 2025 | Goodwin
Atrandi Biosciences, a Vilnius, Lithuania-based biotechnology company, has secured a $25 million Series A funding round. This round was led by Lux Capital with participation from other firms including Vsquared Ventures, Practica Capital, Metaplanet, and GRIDS Capital. The funds are earmarked for Atrandi's expansion into the U.S. market, with plans to open a Boston office and further develop its proprietary Semi-Permeable Capsule (SPC) technology. The technology promises significant advances in single-cell analysis by enabling scalable, single-cell multiomics. The financial and strategic advisory for the round was provided by Goodwin, which assembled a multidisciplinary team covering various legal aspects including technology, life sciences, and global trade, ensuring robust support for Atrandi’s growth trajectory.
Sectors
- Biotechnology
- Financial Services
- Legal Services
Geography
- Lithuania – Atrandi Biosciences is based in Vilnius, Lithuania.
- United States – Atrandi Biosciences plans to expand into the U.S. market, specifically opening an office in Boston.
Industry
- Biotechnology – Atrandi Biosciences is involved in biotechnology, developing technologies for single-cell analysis.
- Financial Services – The transaction involves a significant funding round, necessitating financial and legal advisory services.
- Legal Services – Goodwin provided legal services, advising on the financial transaction and structuring.
Financials
- $25,000,000 – The total value of the Series A funding round raised by Atrandi Biosciences.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Atrandi Biosciences | Target Company | Company | A Vilnius, Lithuania-based biotech firm focusing on single-cell analysis. |
| Lux Capital | Lead Investor | Company | A venture capital firm that led the Series A investment round. |
| Vsquared Ventures | Investor | Company | A participant in Atrandi Biosciences' Series A funding. |
| Practica Capital | Investor | Company | A venture capital firm participating in the funding round. |
| Metaplanet | Investor | Company | An investment firm involved in the Series A round for Atrandi. |
| GRIDS Capital | Investor | Company | A capital firm that contributed to Atrandi's funding round. |
| Goodwin | Legal Advisor | Company | A law firm advising Atrandi Biosciences in the Series A funding round. |